Neuroimmunology diseases involve complex interactions between the nervous system and the immune system, leading to various disorders affecting the central nervous system (CNS). Conditions within this realm encompass autoimmune disorders, neuroinflammatory diseases, and infections that impact the neurological function. Multiple sclerosis (MS) is a prominent neuroimmunology disease characterized by immune-mediated damage to the myelin sheath, affecting communication between nerve cells. Other autoimmune disorders, such as Guillain-Barré syndrome, involve the immune system targeting peripheral nerves. Infections, like viral encephalitis or meningitis, can trigger immune responses that impact the CNS, leading to neurological symptoms. Neuroimmunology research also explores the role of the immune system in neurodegenerative diseases like Alzheimer's and Parkinson's. Understanding the intricate crosstalk between the immune and nervous systems is vital for developing targeted therapies for neuroimmunology diseases. Research in this field aims to unravel the mechanisms underlying these disorders, identify biomarkers for early diagnosis, and advance therapeutic strategies to modulate the immune response and preserve neurological function.
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey
Title : Overcoming biophysical characterization challenges of small antigens in dilute vaccine formulations
Eric Kemp, Merck & Co., United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : A combined LC-MS and immunoassay approach to characterize preservative-induced destabilization of human papillomavirus virus-like particles adsorbed to an aluminum-salt adjuvant
Ria T Caringal, University of Kansas, United States